JP Morgan Chase
VCYT icon

JP Morgan Chase’s Veracyte VCYT Stock Holding History

JP Morgan Chase’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.1M Sell
496,219
-23,910
-5% -$885K ﹤0.01% 2321
2025
Q4 		$21.9M Buy
520,129
+1,279
+0.2% +$51.6K ﹤0.01% 1992
2025
Q3 		$17.8M Buy
518,850
+181,872
+54% +$5.22M ﹤0.01% 2191
2025
Q2 		$9.11M Buy
336,978
+243,111
+259% +$7.04M ﹤0.01% 2642
2025
Q1 		$2.78M Sell
93,867
-341,104
-78% -$13M ﹤0.01% 3617
2024
Q4 		$17.2M Buy
434,971
+88,384
+26% +$3.35M ﹤0.01% 2180
2024
Q3 		$11.8M Sell
346,587
-2,543
-0.7% -$71.5K ﹤0.01% 2467
2024
Q2 		$7.57M Buy
349,130
+268,466
+333% +$5.64M ﹤0.01% 2701
2024
Q1 		$1.79M Sell
80,664
-36,579
-31% -$892K ﹤0.01% 3932
2023
Q4 		$3.23M Sell
117,243
-143,623
-55% -$3.47M ﹤0.01% 3457
2023
Q3 		$5.83M Sell
260,866
-8,063
-3% -$207K ﹤0.01% 2716
2023
Q2 		$6.85M Buy
268,929
+176,275
+190% +$4.27M ﹤0.01% 2623
2023
Q1 		$2.07M Sell
92,654
-292,795
-76% -$7.08M ﹤0.01% 3518
2022
Q4 		$9.15M Buy
385,449
+61,210
+19% +$1.42M ﹤0.01% 2340
2022
Q3 		$5.38M Buy
324,239
+256,867
+381% +$5.78M ﹤0.01% 2681
2022
Q2 		$1.34M Buy
67,372
+12,052
+22% +$243K ﹤0.01% 3869
2022
Q1 		$1.52M Buy
55,320
+9,589
+21% +$274K ﹤0.01% 3961
2021
Q4 		$1.88M Buy
45,731
+2,094
+5% +$92.5K ﹤0.01% 3914
2021
Q3 		$2.03M Sell
43,637
-15,359
-26% -$670K ﹤0.01% 3785
2021
Q2 		$2.36M Buy
58,996
+7,601
+15% +$325K ﹤0.01% 3678
2021
Q1 		$2.76M Buy
51,395
+24,133
+89% +$1.39M ﹤0.01% 3464
2020
Q4 		$1.33M Sell
27,262
-9,672
-26% -$448K ﹤0.01% 3769
2020
Q3 		$1.21M Buy
36,934
+18,889
+105% +$600K ﹤0.01% 3541
2020
Q2 		$467K Buy
18,045
+2,487
+16% +$62K ﹤0.01% 3885
2020
Q1 		$378K Sell
15,558
-68,026
-81% -$1.71M ﹤0.01% 3959
2019
Q4 		$2.33M Buy
83,584
+2,725
+3% +$70.5K ﹤0.01% 3279
2019
Q3 		$1.94M Buy
80,859
+68,063
+532% +$1.81M ﹤0.01% 3439
2019
Q2 		$339K Buy
12,796
+5,893
+85% +$147K ﹤0.01% 4416
2019
Q1 		$173K Sell
6,903
-69,749
-91% -$1.33M ﹤0.01% 4686
2018
Q4 		$964K Sell
76,652
-246,736
-76% -$2.92M ﹤0.01% 3767
2018
Q3 		$3.09M Buy
323,388
+133,469
+70% +$1.47M ﹤0.01% 3138
2018
Q2 		$1.77M Buy
189,919
+60,653
+47% +$427K ﹤0.01% 3499
2018
Q1 		$719K Buy
129,266
+124,156
+2,430% +$768K ﹤0.01% 3850
2017
Q4 		$33K Sell
5,110
-13,795
-73% -$103K ﹤0.01% 5032
2017
Q3 		$160K Buy
+18,905
New +$154K ﹤0.01% 4175
2017
Q2 		– Sell
-49,765
Closed -$456K – 5239
2017
Q1 		$456K Buy
49,765
+26,186
+111% +$214K ﹤0.01% 3750
2016
Q4 		$183K Buy
23,579
+16,941
+255% +$127K ﹤0.01% 4219
2016
Q3 		$51K Buy
+6,638
New +$37.5K ﹤0.01% 4029

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

JP Morgan Chase's VCYT Position: Q1 2026 in Review

JP Morgan Chase reduced its Veracyte (VCYT) stake by 4.6% in Q1 2026, selling an estimated $885K and leaving 496,219 shares worth $15.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2321.

JP Morgan Chase first reported a position in VCYT in Q3 2016 and has held it in 38 quarters since. The position peaked at $21.9M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • JP Morgan Chase held 496,219 shares of Veracyte worth $15.1M as of Q1 2026.
  • JP Morgan Chase sold 23,910 Veracyte shares in Q1 2026, an estimated $885K.
  • Veracyte made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #2321 holding.
  • JP Morgan Chase first reported a position in Veracyte in Q3 2016 and has held it in 38 quarters since.
  • JP Morgan Chase's Veracyte position peaked at $21.9M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.